Your browser doesn't support javascript.
loading
Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
Alam, Khondoker; Farasyn, Taleah; Crowe, Alexandra; Ding, Kai; Yue, Wei.
Afiliação
  • Alam K; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Farasyn T; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Crowe A; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Ding K; Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Yue W; Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
PLoS One ; 12(11): e0186924, 2017.
Article em En | MEDLINE | ID: mdl-29107984
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transportadores de Ânions Orgânicos / Inibidores de Proteassoma / Bortezomib / Membro 1B3 da Família de Transportadores de Ânion Orgânico Carreador de Soluto Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transportadores de Ânions Orgânicos / Inibidores de Proteassoma / Bortezomib / Membro 1B3 da Família de Transportadores de Ânion Orgânico Carreador de Soluto Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2017 Tipo de documento: Article